Cytokinetics, Incorporated (CYTK)
USD 37.35
(-12.98%)
USD 37.35
(-12.98%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 607.37 Million USD | -17.53% |
| 2022 | 736.51 Million USD | 188.75% |
| 2021 | 255.06 Million USD | 87.34% |
| 2020 | 136.15 Million USD | 3.58% |
| 2019 | 131.45 Million USD | 230.23% |
| 2018 | 39.8 Million USD | 25.27% |
| 2017 | 31.77 Million USD | 16.05% |
| 2016 | 27.38 Million USD | 87.04% |
| 2015 | 14.63 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 3000.00 USD | -98.03% |
| 2010 | 152 Thousand USD | -84.57% |
| 2009 | 985 Thousand USD | -62.33% |
| 2008 | 2.61 Million USD | -43.63% |
| 2007 | 4.63 Million USD | -35.06% |
| 2006 | 7.14 Million USD | 7.66% |
| 2005 | 6.63 Million USD | -18.13% |
| 2004 | 8.1 Million USD | 0.38% |
| 2003 | 8.07 Million USD | 14.1% |
| 2002 | 7.07 Million USD | 100.77% |
| 2001 | 3.52 Million USD | 226.69% |
| 2000 | 1.07 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 606.61 Million USD | -0.13% |
| 2024 Q2 | 643.43 Million USD | 6.07% |
| 2023 Q3 | 731.23 Million USD | -0.32% |
| 2023 Q4 | 607.37 Million USD | -16.94% |
| 2023 FY | 607.37 Million USD | -17.53% |
| 2023 Q1 | 735.96 Million USD | -0.07% |
| 2023 Q2 | 733.6 Million USD | -0.32% |
| 2022 Q3 | 722.93 Million USD | 133.39% |
| 2022 Q2 | 309.75 Million USD | 0.67% |
| 2022 Q1 | 307.69 Million USD | 20.63% |
| 2022 FY | 736.51 Million USD | 188.75% |
| 2022 Q4 | 736.51 Million USD | 1.88% |
| 2021 Q3 | 235.87 Million USD | 3.79% |
| 2021 FY | 255.06 Million USD | 87.34% |
| 2021 Q1 | 217.39 Million USD | 59.67% |
| 2021 Q2 | 227.25 Million USD | 4.54% |
| 2021 Q4 | 255.06 Million USD | 8.14% |
| 2020 Q1 | 132.56 Million USD | 0.85% |
| 2020 FY | 136.15 Million USD | 3.58% |
| 2020 Q4 | 136.15 Million USD | -0.28% |
| 2020 Q3 | 136.53 Million USD | 2.69% |
| 2020 Q2 | 132.96 Million USD | 0.3% |
| 2019 Q1 | 41.65 Million USD | 4.64% |
| 2019 Q3 | 48.01 Million USD | -1.53% |
| 2019 Q4 | 131.45 Million USD | 173.75% |
| 2019 FY | 131.45 Million USD | 230.23% |
| 2019 Q2 | 48.76 Million USD | 17.08% |
| 2018 FY | 39.8 Million USD | 25.27% |
| 2018 Q1 | 31.95 Million USD | 0.56% |
| 2018 Q3 | 38.12 Million USD | 24.35% |
| 2018 Q2 | 30.66 Million USD | -4.04% |
| 2018 Q4 | 39.8 Million USD | 4.4% |
| 2017 Q4 | 31.77 Million USD | 55.23% |
| 2017 FY | 31.77 Million USD | 16.05% |
| 2017 Q1 | 25.19 Million USD | -7.98% |
| 2017 Q2 | 22.84 Million USD | -9.33% |
| 2017 Q3 | 20.47 Million USD | -10.39% |
| 2016 Q1 | 29.46 Million USD | 101.28% |
| 2016 FY | 27.38 Million USD | 87.04% |
| 2016 Q4 | 27.38 Million USD | -7.94% |
| 2016 Q2 | 29.6 Million USD | 0.47% |
| 2016 Q3 | 29.74 Million USD | 0.47% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | 14.63 Million USD | 0.0% |
| 2015 FY | 14.63 Million USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | -100.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | 3000.00 USD | -98.03% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q1 | 34 Thousand USD | -77.63% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q1 | 724 Thousand USD | -26.5% |
| 2010 Q4 | 152 Thousand USD | -50.81% |
| 2010 FY | 152 Thousand USD | -84.57% |
| 2010 Q3 | 309 Thousand USD | -36.81% |
| 2010 Q2 | 489 Thousand USD | -32.46% |
| 2009 Q4 | 985 Thousand USD | -26.38% |
| 2009 FY | 985 Thousand USD | -62.33% |
| 2009 Q1 | 14.54 Million USD | 456.1% |
| 2009 Q3 | 1.33 Million USD | -23.85% |
| 2009 Q2 | 1.75 Million USD | -87.92% |
| 2008 Q2 | 3.57 Million USD | -13.04% |
| 2008 FY | 2.61 Million USD | -43.63% |
| 2008 Q1 | 4.11 Million USD | -11.36% |
| 2008 Q4 | 2.61 Million USD | -15.12% |
| 2008 Q3 | 3.08 Million USD | -13.84% |
| 2007 Q2 | 6.6 Million USD | -13.72% |
| 2007 Q3 | 5.54 Million USD | -16.1% |
| 2007 FY | 4.63 Million USD | -35.06% |
| 2007 Q1 | 7.65 Million USD | 7.14% |
| 2007 Q4 | 4.63 Million USD | -16.28% |
| 2006 Q3 | 6.65 Million USD | 8.44% |
| 2006 Q1 | 5.93 Million USD | -10.59% |
| 2006 FY | 7.14 Million USD | 7.66% |
| 2006 Q4 | 7.14 Million USD | 7.36% |
| 2006 Q2 | 6.13 Million USD | 3.42% |
| 2005 Q2 | 6.86 Million USD | -8.3% |
| 2005 Q3 | 6.91 Million USD | 0.67% |
| 2005 Q4 | 6.63 Million USD | -4.02% |
| 2005 FY | 6.63 Million USD | -18.13% |
| 2005 Q1 | 7.49 Million USD | -7.6% |
| 2004 Q3 | 7.66 Million USD | -6.65% |
| 2004 Q4 | 8.1 Million USD | 5.77% |
| 2004 FY | 8.1 Million USD | 0.38% |
| 2004 Q2 | 8.21 Million USD | 8.04% |
| 2004 Q1 | 7.59 Million USD | -5.89% |
| 2003 Q4 | 8.07 Million USD | 0.0% |
| 2003 FY | 8.07 Million USD | 14.1% |
| 2002 FY | 7.07 Million USD | 100.77% |
| 2001 FY | 3.52 Million USD | 226.69% |
| 2000 FY | 1.07 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Absci Corporation | 4.66 Million USD | -12933.755% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -364.85% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 74.077% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -227380.524% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -3046514.165% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -1415.402% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -5327.334% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -503.763% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -3114.464% |
| Chimerix, Inc. | 125 Thousand USD | -485798.4% |
| CRISPR Therapeutics AG | 223 Million USD | -172.356% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -215.322% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -12280.208% |
| Fortress Biotech, Inc. | 60.85 Million USD | -898.049% |
| Fortress Biotech, Inc. | 60.85 Million USD | -898.049% |
| Gritstone bio, Inc. | 40.14 Million USD | -1412.986% |
| Allakos Inc. | 38.21 Million USD | -1489.358% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -145.287% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -1538.051% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -6490.419% |
| Innoviva, Inc. | 446.23 Million USD | -36.111% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -2307022.237% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -13524.338% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -4591.951% |
| ImmuCell Corporation | 10.54 Million USD | -5662.281% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -53888.711% |
| Incyte Corporation | 29.16 Million USD | -1982.755% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -5405.524% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -445930.417% |
| Mustang Bio, Inc. | 1.97 Million USD | -30606.421% |
| MiMedx Group, Inc. | 48.09 Million USD | -1162.756% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 30.19 Million USD | -1911.435% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 5.3 Million USD | -11359.868% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -538.071% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -17.094% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -640.547% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -446497.794% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -831917.808% |
| NextCure, Inc. | 5.94 Million USD | -10109.665% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -58413.776% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 118.85 Thousand USD | -510911.552% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -418777.931% |
| Opthea Limited | 200.53 Million USD | -202.875% |
| Ovid Therapeutics Inc. | 30 Million USD | -1924.577% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| PDS Biotechnology Corporation | 19.5 Million USD | -3013.746% |
| Precigen, Inc. | 5.89 Million USD | -10203.189% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -13840.165% |
| PureTech Health plc | 18.25 Million USD | -3228.071% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -2620.474% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 77.529% |
| Replimune Group, Inc. | 71.99 Million USD | -743.691% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -1053.43% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -1586103.024% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -653.798% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -1712.242% |
| Solid Biosciences Inc. | 23.94 Million USD | -2436.958% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -103194.728% |
| SciSparc Ltd. | 24 Thousand USD | -2530620.833% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -307.321% |
| TG Therapeutics, Inc. | 100.11 Million USD | -506.657% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -9157.324% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -60.995% |
| UroGen Pharma Ltd. | 98.55 Million USD | -516.303% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -1316.646% |
| XOMA Corporation | 118.51 Million USD | -412.473% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -1307.585% |
| AbCellera Biologics Inc. | 71.22 Million USD | -752.788% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -18654.004% |
| Precision BioSciences, Inc. | 7.72 Million USD | -7764.47% |
| Dyadic International, Inc. | 88.87 Thousand USD | -683339.856% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -440025.362% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -2760686.364% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -613408.081% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -7393.806% |
| IGM Biosciences, Inc. | 34.67 Million USD | -1651.768% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -1013.016% |
| Acelyrin, Inc. | 1.19 Million USD | -50768.76% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -13697.66% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -10453.831% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -673830.363% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -2244.436% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -1657.648% |
| Senti Biosciences, Inc. | 33.53 Million USD | -1710.999% |
| Mesoblast Limited | 100.48 Million USD | -504.453% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -675.413% |
| ChromaDex Corporation | 2.57 Million USD | -23487.301% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -753.1% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -2239.289% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -218.11% |
| Novavax, Inc. | 168.01 Million USD | -261.497% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -523.842% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -967.552% |
| Celcuity Inc. | 37.03 Million USD | -1539.979% |
| ContextLogic Inc. | 6 Million USD | -10022.883% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -339.158% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -15879.295% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 88.109% |
| Amarin Corporation plc | 8.73 Million USD | -6851.734% |
| AnaptysBio, Inc. | 16.03 Million USD | -3687.323% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -11153.9% |
| Aptorum Group Limited | 3.05 Million USD | -19758.525% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -6810.604% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -480.618% |
| Ardelyx, Inc. | 51.54 Million USD | -1078.29% |
| Celularity Inc. | 26.17 Million USD | -2220.254% |
| Omeros Corporation | 329.7 Million USD | -84.217% |
| Humacyte, Inc. | 38.6 Million USD | -1473.505% |
| Immunocore Holdings plc | 82.64 Million USD | -634.927% |
| IO Biotech, Inc. | 1.83 Million USD | -32927.352% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -41557.956% |
| Summit Therapeutics Inc. | 103.29 Million USD | -488.027% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 8.32 Million USD | -7194.019% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -527.795% |
| Evogene Ltd. | 10.65 Million USD | -5601.427% |
| CorMedix Inc. | 517.01 Thousand USD | -117377.317% |
| BioLineRx Ltd. | 6.62 Million USD | -9063.745% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -38586.178% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -113.703% |
| scPharmaceuticals Inc. | 38.81 Million USD | -1464.951% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -6938.741% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -2332.996% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -4049053.333% |
| Lisata Therapeutics, Inc. | 137.00 USD | -443337856.204% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -12625.183% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -94506.386% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -15419.246% |
| bluebird bio, Inc. | 224.41 Million USD | -170.642% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -2.407% |
| DBV Technologies S.A. | 4.52 Million USD | -13319.642% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -9675.841% |
| Galecto, Inc. | 66 Thousand USD | -920162.121% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -16014.964% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -35274.083% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -193.462% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -908542.511% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -200.979% |
| ADMA Biologics, Inc. | 130.59 Million USD | -365.085% |
| Clene Inc. | 7.15 Million USD | -8392.352% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -55065.577% |
| Aptose Biosciences Inc. | 621 Thousand USD | -97705.636% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -59980.381% |
| Century Therapeutics, Inc. | 46.65 Million USD | -1201.755% |
| Kura Oncology, Inc. | 9.33 Million USD | -6408.498% |
| Surrozen, Inc. | 882 Thousand USD | -68763.152% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -2174.805% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -6371.742% |
| Autolus Therapeutics plc | 47.91 Million USD | -1167.632% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -8867.562% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -2244.345% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -2537.885% |
| INmune Bio, Inc. | 397 Thousand USD | -152890.68% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -249.561% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -14881.106% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -1859.71% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -413222.309% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -1120.311% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -1346.539% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -1229.247% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -28.309% |
| Verastem, Inc. | 40.08 Million USD | -1415.175% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -5941.108% |
| Histogen Inc. | 4.38 Million USD | -13754.311% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -1170.655% |
| Surrozen, Inc. | 882 Thousand USD | -68763.152% |
| Organovo Holdings, Inc. | 888 Thousand USD | -68297.86% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -702.342% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -652259.727% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -2293.211% |
| Turnstone Biologics Corp. | 1.18 Million USD | -50982.675% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -557122.936% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -906.901% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -640.617% |
| Exelixis, Inc. | 189.94 Million USD | -219.764% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -2526.478% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -552.858% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -33382.525% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -295.443% |
| Insmed Incorporated | 1.19 Billion USD | 49.104% |
| MediWound Ltd. | 6.35 Million USD | -9464.929% |
| OmniAb, Inc. | 22.07 Million USD | -2651.407% |
| Alector, Inc. | 30.45 Million USD | -1894.264% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -498.138% |
| Zai Lab Limited | 8.04 Million USD | -7447.819% |
| AlloVir, Inc. | 16.64 Million USD | -3548.324% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -42.377% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -8140537.984% |
| Aura Biosciences, Inc. | 16.87 Million USD | -3500.314% |
| Immunic, Inc. | 639 Thousand USD | -94950.548% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -1936.866% |
| Veracyte, Inc. | 7.52 Million USD | -7971.402% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 5.814% |
| FibroGen, Inc. | 89.69 Million USD | -577.139% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -13904.45% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -18951.851% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -464028.898% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1641448.649% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -30575.404% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 62.793% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -9997.639% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -33382.525% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -4419.481% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -131937.609% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -2731.972% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -1561.532% |
| Agenus Inc. | 137.32 Million USD | -342.292% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -117380.271% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1242.676% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -1886.567% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -1255.683% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 25.133% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -135156.417% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -823.663% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -192106.646% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -987562.612% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 5.92 Million USD | -10156.983% |
| Pluri Inc. | 29.05 Million USD | -1990.569% |
| Prothena Corporation plc | 10.72 Million USD | -5565.264% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -2959.659% |
| Rallybio Corporation | 173 Thousand USD | -350982.659% |
| Kodiak Sciences Inc. | 100 Million USD | -507.373% |
| Cue Biopharma, Inc. | 4.2 Million USD | -14354.379% |
| MeiraGTx Holdings plc | 72.11 Million USD | -742.182% |
| Annexon, Inc. | 29.19 Million USD | -1980.757% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -54033.066% |
| Moderna, Inc. | - USD | -Infinity% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -37554.867% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -16879.955% |
| Blueprint Medicines Corporation | 610.96 Million USD | 0.587% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -1316.547% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -1147.582% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -2290.856% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -568.17% |
| Elicio Therapeutics, Inc. | 6 Million USD | -10011.087% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -129403.838% |
| Nutriband Inc. | 79.82 Thousand USD | -760771.145% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -13445.339% |
| Vor Biopharma Inc. | 31.83 Million USD | -1808.178% |
| Roivant Sciences Ltd. | 477.85 Million USD | -27.104% |
| Alkermes plc | 287.73 Million USD | -111.091% |
| ProKidney Corp. | 3.61 Million USD | -16724.737% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -79922.793% |
| Arcellx, Inc. | 50.84 Million USD | -1094.652% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 65.007% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -1548.768% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -746.619% |
| Atai Life Sciences N.V. | 15.21 Million USD | -3892.985% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -72001.25% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -238085.49% |
| MediciNova, Inc. | 410.66 Thousand USD | -147801.67% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -44266.18% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -91496.127% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -241.087% |
| Biomea Fusion, Inc. | 7.83 Million USD | -7656.999% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -28149.907% |
| Geron Corporation | 35.05 Million USD | -1632.826% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -5171.42% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -2576.241% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -5970.695% |
| Royalty Pharma plc | 6.13 Billion USD | 90.1% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -5179.209% |
| Imunon, Inc. | 1.13 Million USD | -53211.396% |
| BioAtla, Inc. | 836 Thousand USD | -72552.273% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -587.493% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -12798.131% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -2523.868% |
| Structure Therapeutics Inc. | 4.01 Million USD | -15035.136% |
| 89bio, Inc. | 24.79 Million USD | -2349.579% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -5932.108% |
| aTyr Pharma, Inc. | 13.76 Million USD | -4311.804% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -7589.239% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -2906.053% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -218230.278% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4101.861% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 59.488% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -510.376% |
| Liquidia Corporation | 2.36 Million USD | -25592.597% |
| Entera Bio Ltd. | 256 Thousand USD | -237155.078% |
| GH Research PLC | 631 Thousand USD | -96155.626% |
| Vericel Corporation | 81.85 Million USD | -642.002% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -8635.409% |
| Xencor, Inc. | 14.64 Million USD | -4048.156% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -404138.907% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -404815.333% |
| Vaxcyte, Inc. | 22.11 Million USD | -2646.927% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -6224.167% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -8569.326% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -445930.417% |
| Portage Biotech Inc. | 7000.00 USD | -8676657.143% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -91496.127% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -42403.359% |
| OncoCyte Corporation | 2.2 Million USD | -27457.759% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -907714.065% |
| Purple Biotech Ltd. | 163 Thousand USD | -372521.472% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -9596.248% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -50262.604% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -123853.673% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -23859.487% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -128037.764% |
| United Therapeutics Corporation | 300 Million USD | -102.458% |
| HilleVax, Inc. | 25.24 Million USD | -2306.009% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -265.656% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -64998.928% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -32677.82% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -2921.907% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -2205.196% |
| Windtree Therapeutics, Inc. | 15 Million USD | -3949.153% |
| Curis, Inc. | 1.48 Million USD | -40690.665% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -86951.733% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -10122783.333% |
| BeiGene, Ltd. | 197.61 Million USD | -207.347% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -1070.524% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -45226.343% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -16023.52% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -65349.677% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -3377.26% |
| Adicet Bio, Inc. | 17.7 Million USD | -3330.904% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -56.597% |
| Aditxt, Inc. | 1.04 Million USD | -58203.48% |
| Adagene Inc. | 13.54 Million USD | -4385.757% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4321.438% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -3453.343% |
| Compugen Ltd. | 719 Thousand USD | -84374.687% |
| Generation Bio Co. | 89.77 Million USD | -576.558% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -2637.764% |
| Invivyd, Inc. | 722 Thousand USD | -84023.684% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -1152.264% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -20773808.671% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -15779.033% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -2640652.174% |
| 2seventy bio, Inc. | 244.01 Million USD | -148.91% |
| Instil Bio, Inc. | 81.42 Million USD | -645.911% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -17889.526% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -927342.777% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -230958.909% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -6201.203% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -443.885% |
| Evaxion Biotech A/S | 8.48 Million USD | -7055.035% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -710.641% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -838.535% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -9671.123% |
| Cingulate Inc. | 135.09 Thousand USD | -449476.237% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -2480.284% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -337329.444% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -3383.243% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -64790.278% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -425.955% |
| ImmunityBio, Inc. | 836.95 Million USD | 27.43% |
| Korro Bio, Inc. | 31.21 Million USD | -1845.711% |
| Kineta, Inc. | 150 Thousand USD | -404815.333% |
| BioVie Inc. | 349.89 Thousand USD | -173487.715% |
| Codexis, Inc. | 12.24 Million USD | -4860.982% |
| Celularity Inc. | 26.17 Million USD | -2220.254% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -564.449% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -1177.201% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -344323.148% |
| Cibus, Inc. | 17.67 Million USD | -3336.534% |
| IN8bio, Inc. | 3.37 Million USD | -17874.933% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -839.813% |
| Avalo Therapeutics, Inc. | 2 Million USD | -30268.65% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 56.628% |
| Eyenovia, Inc. | 8.95 Million USD | -6680.812% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -825.042% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1915.373% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -7359.752% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -41557.956% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -2759.841% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -57470.9% |
| Moolec Science SA | 99.04 Thousand USD | -613123.149% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -2098.954% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -102670.389% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -36889.829% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -113215.858% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -1913367.96% |
| Humacyte, Inc. | 38.6 Million USD | -1473.505% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -4784.776% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -32449.464% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -58753.973% |
| Notable Labs, Ltd. | 1.52 Million USD | -39701.638% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4321.438% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -191500.315% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -1117.742% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -467110.0% |
| PepGen Inc. | 17.1 Million USD | -3451.889% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -14490.31% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -104981.834% |
| XOMA Corporation | 118.51 Million USD | -412.473% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -1641448.649% |
| Bionomics Limited | 117.62 Million USD | -416.351% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -10726.613% |
| uniQure N.V. | 130.06 Million USD | -366.977% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -936.65% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -88438.338% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -13904.45% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -43753.646% |
| Altimmune, Inc. | 175 Thousand USD | -346970.286% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -10726.613% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -11889.203% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -618.317% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -6016.546% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -9421.445% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -6016.546% |
| argenx SE | 15.35 Million USD | -3855.797% |
| Immunome, Inc. | 1.34 Million USD | -45226.343% |
| Verona Pharma plc | 48.37 Million USD | -1155.577% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -6490.419% |
| Shattuck Labs, Inc. | 3.4 Million USD | -17732.443% |
| CervoMed Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -714456.471% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -361431.548% |
| Moolec Science SA | 99.04 Thousand USD | -613123.149% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -25922.836% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Achilles Therapeutics plc | 1.07 Million USD | -56347.305% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -4672000.0% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -77.345% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -2380.694% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -24195.017% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -312978.866% |
| Beam Therapeutics Inc. | 159.91 Million USD | -279.819% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -98.215% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -72813.926% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -1015200.391% |
| NeurAxis, Inc. | 27.07 Thousand USD | -2243529.714% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -60637.3% |
| Lumos Pharma, Inc. | 6 Million USD | -10022.883% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -3527.747% |
| Palisade Bio, Inc. | 90 Thousand USD | -674758.889% |
| Nutriband Inc. | 79.82 Thousand USD | -760771.145% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -1399.39% |
| Neurogene Inc. | 13.37 Million USD | -4441.786% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -2212.657% |
| Athira Pharma, Inc. | 1.21 Million USD | -49807.395% |
| HCW Biologics Inc. | 6.3 Million USD | -9534.238% |
| XOMA Corporation | 118.51 Million USD | -412.473% |
| Nektar Therapeutics | 112.62 Million USD | -439.288% |
| Arvinas, Inc. | 800 Thousand USD | -75821.625% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4101.861% |
| Merus N.V. | 10.48 Million USD | -5691.123% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -3980.437% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -4422.846% |
| Rezolute, Inc. | 1.66 Million USD | -36488.735% |
| Clene Inc. | 7.15 Million USD | -8392.352% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -827970.295% |
| BeyondSpring Inc. | 3.36 Million USD | -17955.083% |
| Synlogic, Inc. | 12.49 Million USD | -4762.485% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -1759.912% |
| Krystal Biotech, Inc. | 6.62 Million USD | -9074.819% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -255.357% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -10029.636% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1282062.082% |
| MannKind Corporation | 252.15 Million USD | -140.877% |
| Ikena Oncology, Inc. | 7.18 Million USD | -8359.234% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -305112.563% |
| Gossamer Bio, Inc. | 197.4 Million USD | -207.679% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -116702.5% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -115.895% |
| Mural Oncology plc | 8.91 Million USD | -6715.991% |
| Disc Medicine, Inc. | 1.43 Million USD | -42196.17% |
| Champions Oncology, Inc. | 6.09 Million USD | -9868.374% |
| REGENXBIO Inc. | 82.22 Million USD | -638.699% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -122849.253% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -13598.083% |
| Vaxart, Inc. | 2.62 Million USD | -23055.661% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -223502.24% |
| Cellectis S.A. | 36.24 Million USD | -1575.928% |
| Longeveron Inc. | 1.44 Million USD | -41845.649% |
| Repare Therapeutics Inc. | 1.01 Million USD | -60035.941% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 46.37% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -1256.682% |
| Revolution Medicines, Inc. | 80.57 Million USD | -653.798% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -18833.074% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -343048.588% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -493699.187% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 16.19% |
| Denali Therapeutics Inc. | 44.98 Million USD | -1250.288% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -4757.333% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -449476.237% |
| Passage Bio, Inc. | 22.92 Million USD | -2549.854% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -9957.51% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -93775.27% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -2912.016% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -148964.318% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -51025.673% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -130237.554% |
| OmniAb, Inc. | 22.07 Million USD | -2651.407% |
| Anew Medical, Inc. | 1.54 Million USD | -39339.805% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -1954.714% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -6623.934% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -1853.596% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -14881.106% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -1078.061% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -9439.391% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4198.768% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -90282.887% |
| Alumis Inc. Common Stock | 30.86 Million USD | -1868.156% |
| Equillium, Inc. | 384 Thousand USD | -158070.052% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -9761.552% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -19958.554% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -3071629.126% |
| vTv Therapeutics Inc. | 169 Thousand USD | -359292.308% |
| Bio-Techne Corporation | 319 Million USD | -90.399% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -965.791% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -240.139% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -3842.189% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -4804.894% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -12535.178% |
| Nkarta, Inc. | 82.27 Million USD | -638.268% |
| BioCardia, Inc. | 982 Thousand USD | -61750.611% |
| Iterum Therapeutics plc | 18.95 Million USD | -3104.12% |